AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
暂无分享,去创建一个
[1] J. Nicolas,et al. RIP 140 enhances nuclear receptor-dependent transcription in vivo in yeast. , 1997, Molecular endocrinology.
[2] D. Moras,et al. LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA , 1996 .
[3] M. Parker,et al. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites , 1996, Molecular and cellular biology.
[4] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[5] B. O’Malley,et al. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[7] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[8] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[9] P. Chambon,et al. Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. , 1996, The EMBO journal.
[10] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[11] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[12] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[13] D. Pappin,et al. Identification of phosphorylation sites in the mouse oestrogen receptor , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[14] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[15] P. Kushner,et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.
[16] F. S. French,et al. Androgen receptor defects: historical, clinical, and molecular perspectives. , 1995, Endocrine reviews.
[17] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[18] D. Moore,et al. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.
[19] Y. Sadovsky,et al. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein , 1995, Molecular and cellular biology.
[20] P. Chambon,et al. Activation function 2 (AF‐2) of retinoic acid receptor and 9‐cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF‐2 activity. , 1994, The EMBO journal.
[21] M. Parker,et al. Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] X. Jacq,et al. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor , 1994, Cell.
[23] D. Barettino,et al. Characterization of the ligand‐dependent transactivation domain of thyroid hormone receptor. , 1994, The EMBO journal.
[24] J. Sumpter,et al. Environmentally persistent alkylphenolic compounds are estrogenic. , 1994, Endocrinology.
[25] G. Martin,et al. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.
[26] B. Katzenellenbogen,et al. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. , 1993, Molecular endocrinology.
[27] D. Reinberg,et al. Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Karin,et al. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor) , 1993, Molecular and cellular biology.
[29] M. Parker,et al. Steroid and related receptors. , 1993, Current opinion in cell biology.
[30] B. O’Malley,et al. Identification of a new brain-specific transcription factor, NURR1. , 1992, Molecular endocrinology.
[31] B. O’Malley,et al. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.
[32] E. Appella,et al. H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. , 1992, The EMBO journal.
[33] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[34] K. Umesono,et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.
[35] Philippe Kastner,et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.
[36] J. Y. Chen,et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. , 1992, Cell.
[37] Elisabeth Scheer,et al. Distinct classes of transcriptional activating domains function by different mechanisms , 1990, Cell.
[38] S. Fawell,et al. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Beug,et al. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA , 1990, Cell.
[40] R. Koenig,et al. Mutational analysis identifies a new functional domain of the thyroid hormone receptor. , 1990, Molecular endocrinology.
[41] S. Fawell,et al. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor , 1990, Cell.
[42] H. Samuels,et al. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. , 1989, Molecular endocrinology.
[43] P. Chambon,et al. The transcriptional activation function located in the hormone‐binding domain of the human oestrogen receptor is not encoded in a single exon. , 1989, The EMBO journal.
[44] Michael R. Green,et al. Transcription activation by the adenovirus E1a protein , 1989, Nature.
[45] M. Beato. Gene regulation by steroid hormones , 1989, Cell.
[46] J. Kokontis,et al. Identification of a new member of the steroid receptor super-family by cloning and sequence analysis. , 1988, Biochemical and biophysical research communications.
[47] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[48] J. Milbrandt. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene , 1988, Neuron.
[49] H. Okayama,et al. High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.
[50] M. Sleigh,et al. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. , 1986, Analytical biochemistry.